Viewing Study NCT01235793

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2026-01-03 @ 1:21 AM
Study NCT ID: NCT01235793
Status: TERMINATED
Last Update Posted: 2018-11-20
First Post: 2010-11-05
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: The Addition of Temozolomide to Conditioning for Autologous Transplantation in Relapsed & Refractory CNS Lymphoma
Sponsor: Cedars-Sinai Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None B-Cell Lymphoma Originating in the CNS View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Relapsed View
None Refractory View
None Primary Central Nervous System B-cell Lymphoma View
None Autologous Stem Cell Transplant View
None Temozolomide View
None B-Cell Lymphoma View
None RBEAM View
None Conditioning Regimen View